Published in Biophys J on September 23, 2005
Structure-function analysis of tritrpticin analogs: potential relationships between antimicrobial activities, model membrane interactions, and their micelle-bound NMR structures. Biophys J (2006) 0.95
Effects of protein transduction domain (PTD) selection and position for improved intracellular delivery of PTD-Hsp27 fusion protein formulations. Arch Pharm Res (2016) 0.75
CPP-Assisted Intracellular Drug Delivery, What Is Next? Int J Mol Sci (2016) 0.75
Acetyl-[Asn30,Tyr32]-calcitonin fragment 8-32 forms channels in phospholipid planar lipid membranes. Eur Biophys J (2007) 0.75
Torsion angle dynamics for NMR structure calculation with the new program DYANA. J Mol Biol (1997) 15.40
The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J Biomol NMR (1995) 12.25
Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim Biophys Acta (1986) 7.07
A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem Biophys Res Commun (1980) 6.64
Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med (2004) 6.48
Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem (2002) 6.01
A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol (2001) 3.86
Helical membrane protein folding, stability, and evolution. Annu Rev Biochem (2000) 3.63
Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem (1996) 3.18
An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry (1996) 3.16
Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol (1998) 2.89
Hydrophobic interactions of peptides with membrane interfaces. Biochim Biophys Acta (1998) 2.79
Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry (1992) 2.50
Cell-penetrating peptides. Trends Pharmacol Sci (2000) 2.42
Protein transduction: unrestricted delivery into all cells? Trends Cell Biol (2000) 2.37
Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res (2003) 2.34
The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation. J Immunol Methods (1987) 1.98
Pore formation and translocation of melittin. Biophys J (1997) 1.98
Cell penetrating peptides in drug delivery. Pharm Res (2004) 1.86
Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry (1996) 1.71
Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis? J Neurosci Methods (2000) 1.68
A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res (1997) 1.67
Cell surface adherence and endocytosis of protein transduction domains. Mol Ther (2003) 1.67
TAT peptide internalization: seeking the mechanism of entry. Curr Protein Pept Sci (2003) 1.66
Differentiation between attached and ingested immune complexes by a fluorescence quenching cytofluorometric assay. J Immunol Methods (1983) 1.65
A rapid and simple microfluorometric phagocytosis assay. J Immunol Methods (1993) 1.58
The antennapedia peptide penetratin translocates across lipid bilayers - the first direct observation. FEBS Lett (2000) 1.40
Mode of action of the antibacterial cecropin B2: a spectrofluorometric study. Biochemistry (1994) 1.37
Thermodynamics of lipid-peptide interactions. Biochim Biophys Acta (2004) 1.35
Location of M13 coat protein in sodium dodecyl sulfate micelles as determined by NMR. Biochemistry (1994) 1.30
A brief introduction to cell-penetrating peptides. J Mol Recognit (2003) 1.29
Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles. Pharm Res (2003) 1.17
Location and orientation relative to the micelle surface for glucagon in mixed micelles with dodecylphosphocholine: EPR and NMR studies. Biochim Biophys Acta (1981) 1.16
Getting hydrophilic compounds into cells: lessons from homeopeptides. Curr Opin Neurobiol (1996) 1.16
Cell-penetrating peptides: [corrected] from inception to application. Q Rev Biophys (2004) 1.14
Conformational and associative behaviours of the third helix of antennapedia homeodomain in membrane-mimetic environments. Eur J Biochem (1996) 1.11
Interactions of an antimicrobial peptide, magainin 2, with lipopolysaccharide-containing liposomes as a model for outer membranes of gram-negative bacteria. FEBS Lett (1999) 1.10
Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur J Pharm Biopharm (2004) 1.09
Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection. J Mol Biol (2001) 1.06
Solution structure of human calcitonin in membrane-mimetic environment: the role of the amphipathic helix. Proteins (1998) 1.03
A technique for the study of endocytosis in human oral epithelial cells. Arch Oral Biol (1999) 1.02
Structural requirements for cellular uptake of alpha-helical amphipathic peptides. J Pept Sci (1999) 0.98
Translocation of human calcitonin in respiratory nasal epithelium is associated with self-assembly in lipid membrane. Biochemistry (1998) 0.98
Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58). Biochem J (2004) 0.98
Secondary structure and position of the cell-penetrating peptide transportan in SDS micelles as determined by NMR. Biochemistry (2001) 0.96
Physico-chemical requirements for cellular uptake of pAntp peptide. Role of lipid-binding affinity. Eur J Biochem (2001) 0.96
Membrane interaction and cellular internalization of penetratin peptides. Eur J Biochem (2004) 0.94
Channel formation by salmon and human calcitonin in black lipid membranes. Biophys J (2001) 0.93
Structure and positioning comparison of two variants of penetratin in two different membrane mimicking systems by NMR. Eur J Biochem (2003) 0.93
NMR solution structure and position of transportan in neutral phospholipid bicelles. FEBS Lett (2004) 0.90
Three-dimensional structure and position of porcine motilin in sodium dodecyl sulfate micelles determined by 1H NMR. Biochemistry (1997) 0.90
The position of the cell penetrating peptide penetratin in SDS micelles determined by NMR. FEBS Lett (2001) 0.85
Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models. Pharm Res (2004) 0.84
Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58). Pharm Res (2004) 0.79
Structural investigations of a human calcitonin-derived carrier peptide in a membrane environment by solid-state NMR. Biochemistry (2004) 0.79
Bilayer interaction and localization of cell penetrating peptides with model membranes: a comparative study of a human calcitonin (hCT)-derived peptide with pVEC and pAntp(43-58). Biochim Biophys Acta (2005) 0.79
Cationic liposomal delivery of plasmid to endothelial cells measured by quantitative flow cytometry. Biotechnol Bioeng (1996) 0.78
Calcitonin. Endocrinol Metab Clin North Am (2003) 0.78
Novel daunorubicin-carrier peptide conjugates derived from human calcitonin segments. J Mol Recognit (2003) 0.78
A validated HPLC assay for salmon calcitonin analysis. Comparison of HPLC and biological assay. J Pharm Biomed Anal (1990) 0.76
Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release (2005) 2.17
GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology (2006) 1.60
Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds. Biomaterials (2006) 1.56
Cartilage-like tissue engineering using silk scaffolds and mesenchymal stem cells. Tissue Eng (2006) 1.45
Silk fibroin as a vehicle for drug delivery applications. J Control Release (2010) 1.40
Silk fibroin spheres as a platform for controlled drug delivery. J Control Release (2008) 1.35
Designed armadillo repeat proteins as general peptide-binding scaffolds: consensus design and computational optimization of the hydrophobic core. J Mol Biol (2007) 1.33
Isotope-labeled cross-linkers and Fourier transform ion cyclotron resonance mass spectrometry for structural analysis of a protein/peptide complex. J Am Soc Mass Spectrom (2006) 1.31
Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm (2004) 1.30
Nerve conduits and growth factor delivery in peripheral nerve repair. J Peripher Nerv Syst (2007) 1.29
Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammation. J Exp Med (2008) 1.27
Neuropeptide Y stimulates neuronal precursor proliferation in the post-natal and adult dentate gyrus. J Neurochem (2005) 1.26
PEGylation as a tool for the biomedical engineering of surface modified microparticles. J Pharm Sci (2008) 1.23
Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials (2006) 1.22
Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev (2005) 1.22
Prolyl isomerase PIN1 regulates DNA double-strand break repair by counteracting DNA end resection. Mol Cell (2013) 1.19
On the biomedical promise of cell penetrating peptides: limits versus prospects. J Pharm Sci (2008) 1.18
Silk fibroin matrices for the controlled release of nerve growth factor (NGF). Biomaterials (2007) 1.17
Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation. Structure (2009) 1.16
Using a beta-hairpin to mimic an alpha-helix: cyclic peptidomimetic inhibitors of the p53-HDM2 protein-protein interaction. Angew Chem Int Ed Engl (2004) 1.16
Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. J Control Release (2007) 1.12
Transfer of lipophilic markers from PLGA and polystyrene nanoparticles to caco-2 monolayers mimics particle uptake. Pharm Res (2002) 1.12
Localized insulin-like growth factor I delivery to enhance new bone formation. Bone (2003) 1.12
The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors. Eur J Neurosci (2005) 1.10
Structure and dynamics of helix-0 of the N-BAR domain in lipid micelles and bilayers. Biophys J (2008) 1.10
Peptide drugs to target G protein-coupled receptors. Trends Pharmacol Sci (2010) 1.09
Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur J Pharm Biopharm (2004) 1.09
In vivo characterization of high Basal signaling from the ghrelin receptor. Endocrinology (2009) 1.08
Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape. Biochemistry (2005) 1.08
Transport of surface-modified nanoparticles through cell monolayers. Chembiochem (2005) 1.08
Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors. Biol Chem (2010) 1.08
Characterization of the interaction of interleukin-8 with hyaluronan, chondroitin sulfate, dermatan sulfate and their sulfated derivatives by spectroscopy and molecular modeling. Glycobiology (2011) 1.07
Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells. J Biol Chem (2003) 1.05
Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells. Vaccine (2005) 1.05
Expressed protein ligation. Method and applications. Eur J Biochem (2004) 1.04
Structure-activity studies in a family of beta-hairpin protein epitope mimetic inhibitors of the p53-HDM2 protein-protein interaction. Chembiochem (2006) 1.04
Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages. Pharm Res (2003) 1.03
Optimization strategies for electrospun silk fibroin tissue engineering scaffolds. Biomaterials (2009) 1.03
Promiscuous modification of the nuclear poly(A)-binding protein by multiple protein-arginine methyltransferases does not affect the aggregation behavior. J Biol Chem (2008) 1.02
Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant. Adv Drug Deliv Rev (2013) 1.02
Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. Clin Sci (Lond) (2008) 1.00
Artificial chemokines: combining chemistry and molecular biology for the elucidation of interleukin-8 functionality. J Am Chem Soc (2008) 1.00
The third intracellular loop stabilizes the inactive state of the neuropeptide Y1 receptor. J Biol Chem (2008) 1.00
Surprisingly stable helical conformations in alpha/beta-peptides by incorporation of cis-beta-aminocyclopropane carboxylic acids. Angew Chem Int Ed Engl (2004) 0.99
A Y2 receptor mimetic aptamer directed against neuropeptide Y. J Biol Chem (2001) 0.98
Biochemical characterisation and genetic analysis of aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus. J Mol Biol (2002) 0.98
Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58). Biochem J (2004) 0.98
Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering. Biomaterials (2009) 0.98
Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(L-lysine)-grafted poly(ethylene glycol) conjugate. Pharm Res (2003) 0.97
Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246. Br J Pharmacol (2002) 0.97
Evaluation of pH-dependent membrane-disruptive properties of poly(acrylic acid) derived polymers. Eur J Pharm Biopharm (2003) 0.97
Interactions of lipopolysaccharide and polymyxin studied by NMR spectroscopy. J Biol Chem (2009) 0.97
Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response. J Drug Target (2009) 0.97
Agonist induced receptor internalization of neuropeptide Y receptor subtypes depends on third intracellular loop and C-terminus. Cell Signal (2008) 0.97
Amphiphilic dendrimers: novel self-assembling vectors for efficient gene delivery. Angew Chem Int Ed Engl (2003) 0.96
Glutamate release by neurons evokes a purinergic inhibitory mechanism of osmotic glial cell swelling in the rat retina: activation by neuropeptide Y. J Neurosci Res (2006) 0.96
Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism. J Biol Chem (2007) 0.96
Type I Arginine Methyltransferases PRMT1 and PRMT-3 Act Distributively. J Biol Chem (2009) 0.95
Differentiation restricted endocytosis of cell penetrating peptides in MDCK cells corresponds with activities of Rho-GTPases. Pharm Res (2007) 0.95
Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering. Biomaterials (2009) 0.95
Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications. Eur J Pharm Biopharm (2012) 0.94
Long-acting lipidated analogue of human pancreatic polypeptide is slowly released into circulation. J Med Chem (2011) 0.94
The cell penetrating peptides pVEC and W2-pVEC induce transformation of gel phase domains in phospholipid bilayers without affecting their integrity. Biochemistry (2006) 0.94
DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells. Adv Drug Deliv Rev (2005) 0.94
Neuropeptide Y receptors: how to get subtype selectivity. Front Endocrinol (Lausanne) (2013) 0.94
Cotton wool-like nanocomposite biomaterials prepared by electrospinning: in vitro bioactivity and osteogenic differentiation of human mesenchymal stem cells. J Biomed Mater Res B Appl Biomater (2008) 0.93
Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors. J Mol Biol (2004) 0.93
Peptides and peptide conjugates: therapeutics on the upward path. Future Med Chem (2012) 0.93
Electron paramagnetic resonance backbone dynamics studies on spin-labelled neuropeptide Y analogues. J Pept Sci (2002) 0.92
Illuminating the life of GPCRs. Cell Commun Signal (2009) 0.92
Non-invasive time-lapsed monitoring and quantification of engineered bone-like tissue. Ann Biomed Eng (2007) 0.91
Proteome analysis to study signal transduction of G protein-coupled receptors. Pharmacol Ther (2006) 0.91
Chemical and biological characterization of new Re(CO)3/[99mTc](CO)3 bombesin analogues. Nucl Med Biol (2006) 0.91
New mosquito larvicidal tetranortriterpenoids from Turraea wakefieldii and Turraea floribunda. J Agric Food Chem (2004) 0.90
The support of adenosine release from adenosine kinase deficient ES cells by silk substrates. Biomaterials (2006) 0.90
Microparticle-mediated transfection of non-phagocytic cells in vitro. J Drug Target (2002) 0.90
Kinetic response of a photoperturbed allosteric protein. Proc Natl Acad Sci U S A (2013) 0.89
Identification of a basic surface area of the FADD death effector domain critical for apoptotic signaling. FEBS Lett (2002) 0.89
Residue-resolved stability of full-consensus ankyrin repeat proteins probed by NMR. J Mol Biol (2010) 0.89
Multiple NPY receptors Inhibit GABA(A) synaptic responses of rat medial parvocellular effector neurons in the hypothalamic paraventricular nucleus. Endocrinology (2002) 0.89
Receptor subtype-specific docking of Asp6.59 with C-terminal arginine residues in Y receptor ligands. J Biol Chem (2007) 0.89
Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development. J Pept Sci (2011) 0.88
NMR studies in dodecylphosphocholine of a fragment containing the seventh transmembrane helix of a G-protein-coupled receptor from Saccharomyces cerevisiae. Biophys J (2007) 0.88
Ligand-induced internalization and recycling of the human neuropeptide Y2 receptor is regulated by its carboxyl-terminal tail. J Biol Chem (2010) 0.88
Ghrelin receptor: high constitutive activity and methods for developing inverse agonists. Methods Enzymol (2010) 0.88
The use of sulfonated silk fibroin derivatives to control binding, delivery and potency of FGF-2 in tissue regeneration. Biomaterials (2009) 0.88
Dimerization of adiponectin receptor 1 is inhibited by adiponectin. J Cell Sci (2010) 0.88
Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy. J Immunol Methods (2004) 0.88
Ghrelin--a novel generation of anti-obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues. J Pept Sci (2009) 0.88
Strategies and tools for structure determination of natural products using modern methods of NMR spectroscopy. Chem Biodivers (2005) 0.87
The beta(E)-domain of wheat E(c)-1 metallothionein: a metal-binding domain with a distinctive structure. J Mol Biol (2009) 0.87
Molecular recognition of the NPY hormone family by their receptors. Nutrition (2008) 0.87
Biopolymer-based growth factor delivery for tissue repair: from natural concepts to engineered systems. Tissue Eng Part B Rev (2009) 0.87
In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors. Nucl Med Biol (2002) 0.87
Remodeling of tissue-engineered bone structures in vivo. Eur J Pharm Biopharm (2013) 0.87
Towards improved receptor targeting: anterograde transport, internalization and postendocytic trafficking of neuropeptide Y receptors. Biol Chem (2013) 0.86
Mannose-based molecular patterns on stealth microspheres for receptor-specific targeting of human antigen-presenting cells. Langmuir (2008) 0.86